Evidence map›Paper›PMID 41704861›Full record

ArticleEndoscopy international open2026

Feasibility of repeat non-exposed endoscopic full-thickness resection of recurrent or residual colonic adenoma after previous full-thickness resection.

Andreas Wannhoff, Khalid Takhgiriev, Remy Hosari, Paul Hubbes, Karel Caca

Abstract read
In one paragraph

Article in Endoscopy international open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Andreas WannhoffDepartment of Internal Medicine, Gastroenterology, Haemato-Oncology, Diabetology, and Infectious Diseases, Ludwigsburg Hospital, Ludwigsburg, Germany.ORCID 0000-0002-9660-1323
Khalid TakhgirievDepartment of Internal Medicine, Gastroenterology, Haemato-Oncology, Diabetology, and Infectious Diseases, Ludwigsburg Hospital, Ludwigsburg, Germany.
Remy HosariDepartment of Internal Medicine, Gastroenterology, Haemato-Oncology, Diabetology, and Infectious Diseases, Ludwigsburg Hospital, Ludwigsburg, Germany.
Paul HubbesDepartment of Internal Medicine, Gastroenterology, Haemato-Oncology, Diabetology, and Infectious Diseases, Ludwigsburg Hospital, Ludwigsburg, Germany.
Karel CacaDepartment of Internal Medicine, Gastroenterology, Haemato-Oncology, Diabetology, and Infectious Diseases, Ludwigsburg Hospital, Ludwigsburg, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and study aims: Endoscopic full-thickness resection (EFTR) can be used to treat recurrent or residual colorectal adenomas. No data are available on treatment of recurrences after EFTR, especially on feasibility and safety of repeat EFTR (re-EFTR). Patients and methods: This single-center retrospective study included patients who underwent device-assisted non-exposed re-EFTR in the colorectum. Technical success, adverse events (AEs), and recurrences were analyzed and compared to patients with primary EFTR. Results: Twenty-seven patients who underwent re-EFTR were included. Median age was 75 years (range: 54-85 years) and nine patients were female (33.3%). The indication for re-EFTR was recurrent adenoma in 24 patients (88.9%) and most lesions were in the right-sided colon (n = 22; 81.5%). Technical success was achieved in 22 patients (81.5%). Reasons for failure were failure to reach the lesion in one case and inability to fully mobilize the lesion into the cap in four cases. Follow-up after 2 to 6 months revealed recurrent lesion in four of 24 cases (16.7%) and four more occurred during further follow-up. Surgery was necessary in two cases. AEs occurred in two cases (7.4%). Comparison with primary EFTR showed a trend toward lower technical success (81.5% vs. 100.0%, Conclusions: Repeat EFTR for recurrence after a previous EFTR is feasible in most patients and only a few patients require surgical resection. The rate of recurrence might be higher than that after primary EFTR, yet there are no differences in AEs.

Indexed as

Colorectal cancerEndoscopic resection (polypectomy, ESD, EMRc, ...)Endoscopy Lower GI TractPolyps / adenomas / ...

Identifiers

PMID41704861
PMCPMC12908940

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.